Heightened alpha1A-adrenergic receptor activity suppresses ischaemia/reperfusion-induced Ins(1,4,5)P3 generation in the mouse heart: a comparison with ischaemic preconditioning.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical science

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1042/CS20070110PMID 17696883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An α1A-Adrenergic–Extracellular Signal-Regulated Kinase Survival Signaling Pathway in Cardiac Myocytes

  2007cited by this paper
• Distribution of mRNA and binding sites of adrenoceptors and muscarinic receptors in the rat heart.

  2006cited by this paper
• Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.

  2006cited by this paper
• Rapid Chemically Induced Changes of PtdIns(4,5)P2 Gate KCNQ Ion Channels

  2006cited by this paper
• Inositol phospholipids localized to caveolae in rat heart are regulated by alpha1-adrenergic receptors and by ischemia-reperfusion.

  2006cited by this paper
• α1A- but not α1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism

  2005cited by this paper
• Both α1A- and α1B-adrenergic receptors crosstalk to downregulate β1-ARs in mouse heart: coupling to differential PTX-sensitive pathways

  2005cited by this paper
• Cardiac Type 2 Inositol 1,4,5-Trisphosphate Receptor

  2005cited by this paper
• Ischemia-induced norepinephrine release, but not norepinephrine-derived free radicals, contributes to myocardial ischemia-reperfusion injury.

  2005cited by this paper
• Endothelin-1–Induced Arrhythmogenic Ca2+ Signaling Is Abolished in Atrial Myocytes of Inositol-1,4,5-Trisphosphate(IP3)–Receptor Type 2–Deficient Mice

  2005cited by this paper
• Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice.

  2004cited by this paper
• The role of inositol 1,4,5‐trisphosphate receptors in Ca2+ signalling and the generation of arrhythmias in rat atrial myocytes

  2002cited by this paper
• Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels.

  2002cited by this paper
• Targeted &agr;1A-Adrenergic Receptor Overexpression Induces Enhanced Cardiac Contractility but not Hypertrophy

  2001cited by this paper
• [Up-regulation of inositol 1, 4, 5-trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation].

  2001cited by this paper
• Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart.

  2000cited by this paper
• Ca2+-activated but Not G Protein-mediated Inositol Phosphate Responses in Rat Neonatal Cardiomyocytes Involve Inositol 1,4,5-Trisphosphate Generation*

  2000cited by this paper
• Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts.

  2000cited by this paper
• Reperfusion arrhythmias in the murine heart: their characteristics and alteration after ischemic preconditioning

  1999cited by this paper
• Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active alpha1B-adrenergic receptors.

  1998cited by this paper
• Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs.

  1998cited by this paper
• Analysis of inositol phosphates in heart tissue using anion-exchange high-performance liquid chromatography

  1997cited by this paper
• Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate.

  1996cited by this paper
• Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C.

  1996cited by this paper
• alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling.

  1996cited by this paper
• Regulation of Cardiac Na+,Ca2+ Exchange and KATP Potassium Channels by PIP2

  1996cited by this paper
• Suppression of ventricular arrhythmias during ischemia-reperfusion by agents inhibiting Ins(1,4,5)P3 release.

  1995cited by this paper
• Preconditioning of perfused rat heart inhibits reperfusion-induced release of inositol(1,4,5)trisphosphate.

  1995cited by this paper
• Inositol phosphate release and metabolism during myocardial ischemia and reperfusion in rat heart.

  1995cited by this paper
• Inositol phosphate release and metabolism in rat left atria.

  1995cited by this paper
• Differential regulation of two types of intracellular calcium release channels during end-stage heart failure.

  1995cited by this paper
• alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C.

  1994cited by this paper
• Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy.

  1994cited by this paper
• Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts.

  1994cited by this paper
• Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

  1986cited by this paper

• Adrenoceptors in GtoPdb v.2025.3

  2025cites this paper
• Adrenoceptors in GtoPdb v.2023.3

  2023cites this paper
• Adrenoceptors in GtoPdb v.2023.1

  2023cites this paper
• Inositol 1,4,5-trisphosphate receptors in cardiomyocyte physiology and disease

  2022cites this paper
• ArrhythmoGenoPharmacoTherapy

  2020cites this paper
• Adrenoceptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Role of Phospholipase C in Cardioprotection During Oxidative Stress

  2014cites this paper
• Cardiac Alpha1-Adrenergic Receptors: Novel Aspects of Expression, Signaling Mechanisms, Physiologic Function, and Clinical Importance

  2014cites this paper
• Phospholipase C Signaling in Heart Disease

  2014cites this paper
• No Contribution of IP3-R(2) to Disease Phenotype in Models of Dilated Cardiomyopathy or Pressure Overload Hypertrophy

  2013cites this paper
• Antiarrhythmic properties of some 1,4-disubstituted piperazine derivatives with α1-adrenoceptor affinities.

  2013cites this paper
• Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities.

  2012cites this paper
• Lipid Signaling Pathways in the Heart

  2011cites this paper
• Cardiac and neuroprotection regulated by α1-adrenergic receptor subtypes

  2011cites this paper
• Phospholipase C as a potential target for cardioprotection during oxidative stress.

  2010cites this paper
• FoxO proteins and cardiac pathology.

  2009cites this paper
• Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.

  2008cites this paper
• Ins(1,4,5)P(3) regulates phospholipase Cbeta1 expression in cardiomyocytes.

  2008cites this paper
• Phosphoinositide signalling and cardiac arrhythmias.

  2008cites this paper
• No Contribution of Ip 3 -r(2) to Disease Phenotype in Models of Dilated Cardiomyopathy or Pressure Overload Hypertrophy Cooley Et Al: No Effect of Ip 3 -r(2) on Dcm or Hypertrophy

  year unknowncites this paper